Insiders who reported open-market trades in the last 12 months at the companies Maggie Yuen files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Sven Wehrwein - $1.32M in ATRC purchases and sales in the last 12 months
Salvatore Privitera - $880K in ATRC purchases and sales in the last 12 months
Vinayak Doraiswamy - $523K in ATRC purchases and sales in the last 12 months
Karl S. Dahlquist - $458K in ATRC purchases and sales in the last 12 months
Justin J. Noznesky - $433K in ATRC purchases and sales in the last 12 months
Regina E. Groves - $288K in ATRC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Maggie Yuen is a corporate insider, tracked as Director of AtriCure, Inc. (ATRC). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Maggie Yuen submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Maggie Yuen been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($1.57M) across all tracked filings.
Maggie Yuen is Director of AtriCure, Inc. (ATRC). 10 SEC Form 4 filings on record going back to 2024, most recently on 7 August 2026. Most recent open-market trade: sold $134K of ATRC on 7 August 2026. Lifetime open-market sales: $1.57M.
Recent transactions
16
The latest 16 SEC Form 4 transactions reported by Maggie Yuen.
InsiderAlpha's records for Maggie Yuen go back to 2024: 10 primary Form 4 filings, an average of 3.3 per year. 1 recorded transaction carries a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
